多学科标准化管理模式治疗腹膜后脂肪肉瘤的临床与手术效果:来自复旦大学附属中山医院的循证临床实践经验
该回顾性比较研究在复旦大学附属中山医院于2011年4月至2021年3月开展,纳入139例多学科团队(MDT)管理患者和382例非MDT管理患者,经倾向性评分匹配后,MDT组1年、3年、5年总生存率分别为89.5%、70.5%、62.9%,非MDT组分别为77.1%、49.8%、45.1%。MDT组诊断一致性显著更高(92.5% vs 83.6%,P=0.042),围术期死亡率和术后并发症显著降低(P=0.036和P=0.002),但住院时间和30天再手术无显著关联(P=0.232和P=0.447)。
要点
- MDT管理组1年、3年、5年总生存率分别为89.5%、70.5%、62.9%,非MDT组分别为77.1%、49.8%、45.1%。
- MDT组诊断一致性显著高于非MDT组(92.5% vs 83.6%,P=0.042)。
- MDT参与与围术期死亡率(P=0.036)和术后并发症(P=0.002)显著降低相关,但与住院时间(P=0.232)和30天再手术(P=0.447)无显著关联。
核心结论
- 研究结果表明,MDT管理可能改善临床结局、提高诊断准确性,并减少术后住院时间、并发症和围术期死亡率。
- 该干预还可能提高接受手术的腹膜后脂肪肉瘤患者的疾病意识和术后依从性。
- 然而,证据质量被认为较低,需要设计稳健的前瞻性研究;尽管如此,这些结果值得考虑。
研究设计与样本
- 本研究为回顾性比较研究,于2011年4月至2021年3月在中国复旦大学附属中山医院的专科评估中心开展。
- 共筛查521份记录,139例患者被纳入并定义为MDT队列,同期382例未接受MDT管理的患者被纳入并定义为非MDT队列。
- 采用倾向性评分匹配以减轻选择偏倚,并使用单变量和多变量Cox比例风险模型评估MDT对术后生存的影响。
- 使用预先指定的问卷调查MDT管理对意识和治疗依从性的提升作用;数据分析于2023年1月至2023年8月进行。
主要发现
- MDT队列的原发性腹膜后脂肪肉瘤数量较少,但肿瘤分级更高且R2切除比例更大。
- 倾向性评分匹配后,MDT队列的1年、3年、5年总生存率分别为89.5%、70.5%、62.9%,非MDT队列分别为77.1%、49.8%、45.1%。
- MDT组的诊断一致性显著优于非MDT队列(92.5% vs 83.6%,P=0.042)。
- MDT参与与围术期死亡率显著降低相关(P=0.036),与术后并发症显著降低相关(P=0.002);与住院时间(P=0.232)和30天再手术(P=0.447)无显著关联。
- MDT组腹膜后脂肪肉瘤患者的疾病意识和术后依从性更强。
关键数值与推荐
- MDT队列1年总生存率89.5%,非MDT队列77.1%。
- MDT队列3年总生存率70.5%,非MDT队列49.8%。
- MDT队列5年总生存率62.9%,非MDT队列45.1%。
- 诊断一致性MDT组92.5% vs 非MDT组83.6%(P=0.042)。
- 围术期死亡率P=0.036,术后并发症P=0.002,住院时间P=0.232,30天再手术P=0.447。
临床怎么用
- 原文结论指出MDT管理可能改善临床结局、提高诊断准确性并减少术后住院时间、并发症和围术期死亡率。
- 原文结论指出该干预还可能提高腹膜后脂肪肉瘤手术患者的疾病意识和术后依从性。
- 原文结论强调证据质量较低,需要设计稳健的前瞻性研究,但这些结果值得考虑。
局限性
- 证据质量被认为较低。
- 需要设计稳健的前瞻性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To assess the correlation between clinical outcomes and diagnostic accuracy of evaluations carried out by a preoperative multidisciplinary team versus standard surgical care for patients with retroperitoneal liposarcoma undergoing surgery. METHODS: This comparative study was conducted retrospectively at a specialist assessment center within Zhongshan Hospital, Fudan University, China, between April 2011 and March 2021. Patients were assigned to a multidisciplinary team or nonmultidisciplinary team cohort based on referral to the multidisciplinary team. The primary outcome measured was long-term clinical prognosis, with other outcomes including diagnostic accuracy, 30-day reoperation, duration of stay, perioperative mortality, and medical complications. To mitigate selection bias, we conducted propensity-score matching. Uni- and multivariable Cox proportional hazard models were then used to evaluate the effect of multidisciplinary teams on postoperative survival. The previously specified questionnaire was used to measure the enhancement of awareness and treatment adherence facilitated by multidisciplinary team management. Data analysis was carried out between January 2023 and August 2023. RESULTS: Of the 521 records that were screened, 139 patients were deemed eligible for inclusion and defined as the multidisciplinary team cohort. At the same time, 382 patients without multidisciplinary team management were also included during that period and defined as the nonmultidisciplinary team cohort. The multidisciplinary team cohort exhibited lower numbers of primary retroperitoneal liposarcoma but a higher tumor grade and a greater proportion of R2 resection. After propensity-score matching, the 1-, 3-, and 5-year overall survival rates were 89.5%, 70.5%, and 62.9%, respectively, in the multidisciplinary team cohort, and 77.1%, 49.8%, and 45.1% in the nonmultidisciplinary team cohort. The diagnostic consistency of the multidisciplinary team group was significantly superior to that of the nonmultidisciplinary cohort (92.5% vs 83.6%, P = .042). Although no significant links were shown with duration of stay (P = .232) and 30-day reoperation (P = .447), the multidisciplinary team participation was linked to a substantial decrease in perioperative mortality (P = .036) and postoperative complications (P = .002). Additionally, the multidisciplinary team group indicated stronger illness awareness and postoperative adherence among individuals with retroperitoneal liposarcoma. CONCLUSION: The study's findings indicate that multidisciplinary team management could result in improved clinical outcomes, higher diagnostic accuracy, and reduced duration of postoperative stays, complications, and perioperative mortality. The intervention may also enhance disease awareness and postoperative compliance in retroperitoneal liposarcoma patients who undergo surgery. However, evidence quality was deemed low, and prospective studies with robust designs are required. Nonetheless, these results are worth considering.
引用
- Fan P, Tao P, Wang J, et al. Clinical and surgical effectiveness of the multi-disciplinary standardized management model in the treatment of retroperitoneal liposarcoma: Evidence-based clinical practice experience from Fudan Zhongshan. Surgery. 2024. PMID: 38395638. doi:10.1016/j.surg.2024.01.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。